Julie Navez

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Cancers

Cells

Acta chirurgica Belgica

Biomedicines

Hôpital Erasme

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hôpital Erasme

Belgium

Resident surgeon :: Department of Digestve Surgery and Abdominal Transplantation

Hôpital Beaujon

France

Chef de clinique-assistant :: Department of Hepato-Bilio-Pancreatic Surgery and Transplantation

Cliniques universitaires Saint-Luc

Belgium

Resident in Surgery :: Department of Abdominal Surgery and Transplantation

Hôpital de la Croix-Rousse

France

Resident in Surgery :: Department of Abdominal Surgery and Transplantation

Centre Hospitalier de Jolimont-Lobbes

Belgium

Resident in Surgery :: Department of Digestive, Cardiovascular and Thoracic Surgery

Cliniques universitaires Saint-Luc

Belgium

Resident in Surgery :: Department of Abdominal Surgery and Transplantation

Publications

Rita Saúde-Conde, Benjelloun El Ghali, Julie Navez, Christelle Bouchart, Jean-Luc Van Laethem
Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better? Cancers 16 (13) (2024)
Rita Saúde-Conde, Ayça Arçay Öztürk, Kosta Stosic, Oier Azurmendi Senar, Julie Navez, Christelle Bouchart, Tatjana Arsenijevic, Patrick Flamen, Jean-Luc Van Laethem
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging. Biomedicines 12 (3) (2024)
Rita Saúde-Conde, Ayça Arçay Öztürk, Kosta Stosic, Oier Azurmendi Senar, Julie Navez, Christelle Bouchart, Tatjana Arsenijevic, Patrick Flamen, Jean-Luc Van Laethem
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging. Biomedicines 12 (3) (2024)
Rita Saúde-Conde, Benjelloun El Ghali, Julie Navez, Christelle Bouchart, Jean-Luc Van Laethem
Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better? Cancers 16 (13) (2024)
Kosta Stosic, Oier Azurmendi Senar, Jawad Tarfouss, Christelle Bouchart, Julie Navez, Jean-Luc Van Laethem, Tatjana Arsenijevic
A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. Cells 13 (1) (2023)
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, Tatjana Arsenijevic, Julie Navez, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy? Cancers 15 (3) (2023)
Kosta Stosic, Oier Azurmendi Senar, Jawad Tarfouss, Christelle Bouchart, Julie Navez, Jean-Luc Van Laethem, Tatjana Arsenijevic
A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. Cells 13 (1) (2023)
Marie-Lucie Racu, Dana Bernardi, Aniss Chaouche, Egor Zindy, Julie Navez, Patrizia Loi, Calliope Maris, Jean Closset, Jean-Luc Van Laethem, Christine Decaestecker, Isabelle Salmon, Nicky D'Haene
SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy. Cancers 15 (15) (2023)
Julie Navez, Christelle Bouchart, Laura Mans, Soline Devos, Patrizia Loi, Jean Closset, Jean-Luc Van Laethem
Neoadjuvant chemotherapy associated with isotoxic high-dose stereotactic body radiotherapy does not increase postoperative complications after pancreaticoduodenectomy for nonmetastatic pancreatic cancer. Journal of surgical oncology (2023)
Kosta Stosic, Oier Azurmendi Senar, Jawad Tarfouss, Christelle Bouchart, Julie Navez, Jean-Luc Van Laethem, Tatjana Arsenijevic
A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. Cells 13 (1) (2023)
Kosta Stosic, Oier Azurmendi Senar, Jawad Tarfouss, Christelle Bouchart, Julie Navez, Jean-Luc Van Laethem, Tatjana Arsenijevic
A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. Cells 13 (1) (2023)
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, Tatjana Arsenijevic, Julie Navez, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy? Cancers 15 (3) (2023)
Martin Manderlier, Julie Navez, Matthieu Hein, Jean-Luc Engelholm, Jean Closset, Maria Antonietta Bali, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation. Cancers 14 (23) (2022)
Martin Manderlier, Julie Navez, Matthieu Hein, Jean-Luc Engelholm, Jean Closset, Maria Antonietta Bali, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation. Cancers 14 (23) (2022)
Martin Manderlier, Julie Navez, Matthieu Hein, Jean-Luc Engelholm, Jean Closset, Maria Antonietta Bali, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation. Cancers 14 (23) (2022)
Martin Manderlier, Julie Navez, Matthieu Hein, Jean-Luc Engelholm, Jean Closset, Maria Antonietta Bali, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation. Cancers 14 (23) (2022)
Julie Frezin, Julie Navez, Paryse Johnson, Philippe Bouchard, Sebastien Drolet
Colorectal resection in end-stage renal disease (ESRD) patients: experience from a single tertiary center. Acta chirurgica Belgica (2021)
Julie Navez, Christelle Bouchart, Diane Lorenzo, Maria Antonietta Bali, Jean Closset, Jean-Luc van Laethem
What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact? Annals of surgical oncology 28 (11) (2021)
Gilles Tilmans, Julie Navez, Mina Komuta, Thibaud Saussez, Jan Lerut
Solitary prostate cancer liver metastasis: an exceptional indication for liver resection. Acta chirurgica Belgica 121 (6) (2020)
Julie Navez, Jean-François Gigot, Pierre H Deprez, Pierre Goffette, Laurence Annet, Francis Zech, Catherine Hubert
Long-term results of secondary biliary repair for cholecystectomy-related bile duct injury: results of a tertiary referral center. Acta chirurgica Belgica 120 (2) (2019)

Julie Navez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Julie Navez